Overview
Allergic rhinitis is a common condition in children. Second generation oral antihistamine are first line treatment for allergic diseases. Bilastine is most recent antihistamine approved by DCGI, India. Take a look at the expert’s opinion about bilastine and its use in children.
Faculty
Prof. Nikolaos G. Papadopoulos
MD, PhD, FAAAAI, FRCP
Professor of Allergy & Paediatric Allergy, University of Manchester, UK; Professor in Allergology- Pediatric Allergology, University of Athens, Greece; Head of Allergy Department, 2nd Pediatric Clinic, University of Athens; Board Member of Global Allergy & Asthma European Network (GA2LEN); Respiratory Syncytial Virus Network (ReSViNET) and ARIA Past president of Respiratory Effectiveness Group (REG) Past president of European Academy of Allergy & Clinical Immunology (EAACI)Resources
External Resources
Bilastine in Children: Understanding Principles and Practice from The Expert’s Diary
Also Read
Conference Highlights
Conference Highlights
Conference Highlights
